The University of Oklahoma Health Sciences Center is a public medical school in Oklahoma City, Oklahoma. It is the health sciences branch of the University of Oklahoma and serves as the primary place of instruction for many of Oklahoma's health professions.

During the past decade, University of Oklahoma Health Sciences Center conducted 521 clinical trials. In the 10-year time frame, 521 clinical trials started and 370 clinical trials were completed, i.e. on average, 71% percent of trials that started reached the finish line to date. In the past 5 years, 176 clinical trials started and 164 clinical trials were completed. i.e. 93.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Oklahoma Health Sciences Center" #1 sponsor was "National Cancer Institute (NCI)" with 312 trials, followed by "University of Oklahoma" with 123 trials sponsored, "Children's Oncology Group" with 98 trials sponsored, "SWOG Cancer Research Network" with 60 trials sponsored and "Gynecologic Oncology Group" with 60 trials sponsored. Other sponsors include 499 different institutions and companies that sponsored additional 225 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Oklahoma Health Sciences Center" #1 collaborator was "National Cancer Institute (NCI)" with 374 trials as a collaborator, "NRG Oncology" with 93 trials as a collaborator, "University of Oklahoma" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 15 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 15 trials as a collaborator. Other collaborators include 481 different institutions and companies that were collaborators in the rest 319 trials.

According to Clinical.Site data, the most researched conditions in "University of Oklahoma Health Sciences Center" are "Recurrent Ovarian Carcinoma" (35 trials), "Recurrent Fallopian Tube Carcinoma" (28 trials), "Recurrent Primary Peritoneal Carcinoma" (27 trials), "Recurrent Neuroblastoma" (23 trials) and "Cervical Adenocarcinoma" (22 trials). Many other conditions were trialed in "University of Oklahoma Health Sciences Center" in a lesser frequency.

Most popular intervention types in "University of Oklahoma Health Sciences Center" are "Drug" (807 trials), "Other" (437 trials), "Biological" (293 trials), "Procedure" (248 trials) and "Radiation" (185 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (235 trials), "Quality-of-Life Assessment" (127 trials), "Questionnaire Administration" (88 trials), "Placebo" (84 trials) and "Carboplatin" (83 trials). Other intervention names were less common.

The vast majority of trials in "University of Oklahoma Health Sciences Center" are 872 trials for "All" genders, 241 trials for "Female" genders and 34 trials for "Male" genders.

Currently, there are 523 active trials in "University of Oklahoma Health Sciences Center". 2 are not yet recruiting, 234 are recruiting, 285 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 490 completed trials in University of Oklahoma Health Sciences Center, 19 suspended trials, and 68 terminated clinical trials to date.

Out of the total trials that were conducted in University of Oklahoma Health Sciences Center, 109 "Phase 1" clinical trials were conducted, 465 "Phase 2" clinical trials and 408 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 24 trials, and there were also 120 trials that are defined as “Not Applicable".

University of Oklahoma Health Sciences Center has several departments that took part in Clinical trials: "Univeristy of Oklahoma Health Sciences Center Dept. Anesthesiology" - 6 trials, "William C. Orr, Ph.D." - 3 trials, "University of Oklahoma, Physician's Child Study Center" - 2 trials, "University of Oklahoma College of Dentistry Graduate Periodontics" - 2 trials, "Department of Pediatrics, University of Oklahoma Health Sciences" - 2 trials, "OU Health Sciences Center - Dept. of Dermatology" - 2 trials